Brief: Carsgen Therapeutics Posts Group Revenue Of RMB125.7 Million For Year
06/03/2026 13:15
March 6 (Reuters) - CARsgen Therapeutics Holdings Ltd 2171.HK: GROUP'S REVENUE RMB125.7 MILLION FOR YEAR FY NET LOSS RMB103 MILLION Further company coverage: 2171.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer